DKBmed Radio

Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here to stay? *Immunity evasiveness of Omicron BA.4 and BA.5 *Expectations for the fall and winter 2022 *Thoughts on upcoming booster reformulation *Should you get a booster now or wait?Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-28-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of MedicineMichael Mina, MD, PhD, Chief Science Officer, eMed, Epidemiologist, Immunologist and Physician

Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags — warnings that something about the patient’s condition does not meet the accepted MS diagnostic criteria — that need to be investigated?Join us in thiseMultipleSclerosis Review podcast, as Neuroimmunologist Dr. Gabrielle Macaron from Saint Joseph University’s Hotel Dieu de France Hospital in Beirut, Lebanon, and the Cleveland Clinic’s Mellen Center for Multiple Sclerosis, explains strategies to reduce misdiagnosis of MS.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.

In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What doesn’t? What does the evidence say?Join us as Dr. W. Oliver Tobin from the Mayo Clinic discusses these questions in this eMultipleSclerosis Review podcast.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in thiseHIV Review podcast.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.

What was it like for a frontline critical care pulmonologist at the very beginning of the COVID-19 epidemic? On the frontlines as the epidemic became pandemic? What’s it like today, with new variants and new in-patient and out-patient treatments? What are the key differences between then and now, what have we learned, and how can we be better prepared for next time?Join us for this ePulmonology Review Special Edition podcast, as Dr. Brian Garibaldi from the Johns Hopkins’ Division of Pulmonary and Critical Care Medicine takes us through his experiences battling COVID 19: Then and Now.Take ourpost-testto claim CME credits.

Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care?Join us for thiseCysticFibrosis Review podcast, as Dr. D.B. Sanders from the Indiana University School of Medicine explains how these questions can affect clinical care.Take ourpost-testto claim CME credits.Read this podcast's companion newsletter here.

Dr. Paul Auwaerter discusses COVID-19 vaccine boosters. Topics: *Should your patients get the booster now or wait? *FDA advisory committee votes to include Omicron component in COVID-19 booster vaccines *COVID-19 case and mortality projections for this winter *Booster timing for children and adultsPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-6-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes?That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in thiseCysticFibrosis Reviewpodcast.Take ourpost-testto claim CME credits.Read this podcast's companion newsletter here.

Dr. Paul Auwaerter discusses the current state of COVID-19 including treatment updates. Topics: *Information on new Omicron subvariants *CDC advisory about rebound COVID-19 *Latest treatment information *Post-COVID conditionsPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/6-1-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine